RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD.

Cancer Med · 2020 · PMC6997098 · PMID 31804006

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

Although reasons are unclear, the prognostic effect of NOTCH1 mutation in T‐ALL might not be significant if patients are treated with non‐BFM protocols.

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.